R
TransCode Therapeutics (RNAZ)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About TransCode Therapeutics (RNAZ)
TransCode Therapeutics, Inc. is a ribonucleic acid (RNA) oncology company. Its lead therapeutic candidate, TTX-MC138, targets microRNA-10b (miRNA-10b), a regulator of metastatic cell viability in a range of cancers, including breast, pancreatic, ovar... Read more
- USD7.07
- USD7.20
- USD6.82
- USD1.05k
- -10.50%
- --
- 21.60k
- 50.81k
- 6M
- 6.15
- -99.30%
Stock News
4 hours ago
The Trade Desk and HOY Expand Strategic Partnership to Advance Programmatic CTV Advertising in Hong Kong
Yahoo
6 hours ago
Galiano Gold: An Organically Funded Growth Story In Ghana
SeekingAlpha
yesterday
You have to spend a year’s salary to really get the most out of the new Chase Sapphire Reserve card
MarketWatch
yesterday
Amazon CEO makes a big prediction on AI — plus, Salesforce hikes prices and a housing market update
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
